ReposiTrak (TRAK) Q3 2025 earnings summary

Executive summary

• Achieved 16% year-over-year revenue growth to $5.9 million in Q3, with net income up 27% to $2 million and 98% recurring revenue, driven by cross-selling across traceability, compliance, and supply chain segments.

• Operating income rose 43% to $1.8 million, and diluted EPS increased to $0.10 from $0.08 per share.

• Cash and cash equivalents increased to $28.1 million as of March 31, 2025, with no bank debt and strong working capital.

• Growth was supported by regulatory and retailer-driven traceability requirements, with onboarding of traceability customers exceeding expectations.

• Deferred revenue remains strong at $3.7 million, indicating future growth.

Financial highlights

• Quarterly revenue was $5,913,732, up 16% year-over-year; year-to-date revenue up 10.3% to $16.9 million.

• Net income for the quarter was $1,965,788; nine-month net income was $5,182,023, both showing year-over-year growth.

• Operating income for the quarter was $1,808,853, up from $1,262,343 a year ago; operating expenses rose 7% in Q3.

• Cash provided by operating activities for the nine months was $6,763,371, a 38% increase year-over-year.

• Gross margin target remains at 80%, with current contribution margin at 50% for incremental revenue.

Outlook and guidance

• Annual revenue growth target of 10%-20% reaffirmed, with expectations to double historical $20 million annual revenue over the next several years.

• Margin expansion anticipated as onboarding and marketing costs flatten over the next 12-20 months.

• Management expects continued growth in recurring subscription revenue, especially in traceability, as regulatory and retailer mandates drive adoption.

• Company believes existing cash and cash flow from operations are sufficient to fund requirements for at least the next twelve months.

• Plan to return 50% of annual cash from operations to shareholders, with the remainder retained.